Abdelshaheed, Christina, Awal, Wasim, Zhang, Geoffrey, Gilbert, Steve, Gallacher, Daniel C., McLachlan, Andrew, Day, Ric, Ferreira, Giovanni, Jones, Caitlin, Ahedi, Harbeer, Tamrakar, Mamata, Blyth, Fiona, Stanaway, Fiona and Maher, Christopher (2022) Efficacy, tolerability, and dose-dependent effects of opioid analgesics for osteoarthritis : systematic review and meta-analysis. The Medical Journal of Australia, 216 (6). pp. 305-311. doi:10.5694/mja2.51392

Gallacher, Daniel C., Stallard, Nigel, Kimani, Peter K., Gökalp, Elvan and Branke, Juergen (2022) Development of a model to demonstrate the impact of NICE cost-effectiveness assessment on health utility for targeted medicines. Health Economics, 31 (2). pp. 417-430. doi:10.1002/hec.4459

Gallacher, Daniel C., Kimani, Peter K. and Stallard, Nigel (2022) Biased survival predictions when appraising health technologies in heterogeneous populations. PharmacoEconomics - Open . pp. 109-120. doi:10.1007/s40273-021-01082-x

Carter, Jemima, Bick, Debra, Gallacher, Daniel and Chang, Yan‐Shing (2022) Mode of birth and development of maternal postnatal post‐traumatic stress disorder : a mixed‐methods systematic review and meta‐analysis. Birth . doi:10.1111/birt.12649 (In Press)

Mottram, Rebecca, Knerr, Wendy Lynn, Gallacher, Daniel C., Fraser, Hannah, Al-Khudairy, Lena, Ayorinde, Abimbola, Williamson, Sian, Nduka, Chidozie U., Uthman, Olalekan A., Johnson, Samantha Ann, Tsertsvadze, Alexander, Stinton, Christopher, Taylor-Phillips, Sian and Clarke, Aileen (2021) Factors associated with attendance at screening for breast cancer : a systematic review and meta-analysis. BMJ Open, 11 (11). e046660. doi:10.1136/bmjopen-2020-046660

Achana, Felix A., Gallacher, Daniel C., Oppong, Raymond, Kim, Sungwook, Petrou, Stavros, Mason, James and Crowther, Michael (2021) Multivariate generalised linear mixed-effects models for the analysis of clinical trial-based cost-effectiveness data. Medical Decision Making, 41 (6). pp. 667-684. doi:10.1177/0272989X211003880

Achana, Felix A., Gallacher, Daniel C., Oppong, Raymond, Kim, Sungwook, Petrou, Stavros, Mason, James and Crowther, Michael (2021) Multivariate generalized linear mixed-effects models for the analysis of clinical trial-based cost-effectiveness data. Medical Decision Making, 41 (6). pp. 667-684. doi:10.1177/0272989X211003880

Gallacher, Daniel, Kimani, Peter and Stallard, Nigel (2021) Extrapolating parametric survival models in Health Technology Assessment using model averaging : a simulation study. Medical Decision Making, 41 (4). pp. 476-484. doi:10.1177/0272989x21992297

Gallacher, Daniel C., Stallard, Nigel and Kimani, Peter K. (2021) Extrapolating parametric survival models in health technology assessment : a simulation study. Medical Decision Making, 41 (1). pp. 37-50. doi:10.1177/0272989X20973201

Bannon, Christopher, Gallacher, Daniel C., Hanson, Petra, Randeva, Harpal S., Weickert , Martin and Barber, Thomas M. (2020) Systematic review and meta-analysis of the metabolic effects of modified-release hydrocortisone versus standard glucocorticoid replacement therapy in adults with adrenal insufficiency. Clinical Endocrinology, 93 (6). pp. 637-651. doi:10.1111/cen.14275

Fraser, Hannah, Gallacher, Daniel C., Achana, Felix A., Court, Rachel A., Taylor-Phillips, Sian, Nduka, Chidozie U., Stinton, Chris, Willans, Rebecca, Gill, Paramjit and Mistry, Hema (2020) Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat : systematic reviews and economic evaluation. Health Technology Assessment, 24 (31). pp. 1-232. doi:10.3310/hta24310

Gallacher, Daniel C., Auguste, Peter, Royle, Pamela, Mistry, Hema and Armoiry, Xavier (2019) A systematic review of economic evaluations assessing the cost-effectiveness of licensed drugs used for previously treated epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced/metastatic non-small cell lung cancer. Clinical Drug Investigation, 39 . pp. 1153-1174. doi:10.1007/s40261-019-00859-5

Smyth, Michael A., Gallacher, Daniel C., Kimani, Peter K., Ragoo, Mark, Ward, Matthew and Perkins, Gavin D. (2019) Derivation and internal validation of the screening to enhance prehospital identification of sepsis (SEPSIS) score in adults on arrival at the emergency department. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 27 (1). 67. doi:10.1186/s13049-019-0642-2

Gallacher, Daniel C., Auguste, Peter and Connock, M. (2019) How do pharmaceutical companies model survival of cancer patients? A review of NICE Single Technology Appraisals in 2017. International Journal of Technology Assessment in Health Care, 35 (2). pp. 160-167. doi:10.1017/S0266462319000175

Kearney, Rebecca S., McKeown, Rebecca, Gallacher, Daniel C., Brown, Jaclyn, Mistry, Dipesh, Parsons, Nick, Young, Jonathan and Costa, Matthew (2019) Ankle injury rehabilitation (AIR): a feasibility randomised controlled trial comparing functional bracing to plaster cast in the treatment of adult ankle fractures. Pilot and Feasibility Studies, 5 (1). doi:10.1186/s40814-019-0441-6

Gallacher, Daniel C., Armoiry, Xavier, Auguste, Peter, Court, Rachel A., Mantopoulos, Theodoros, Patterson, Jacoby, De Santis, Maria , Cresswell, Joanne and Mistry, Hema (2019) Pembrolizumab for previously treated advanced or metastatic urothelial cancer : an evidence review group perspective of a NICE single technology appraisal. PharmacoEconomics, 37 . pp. 19-27. doi:10.1007/s40273-018-0689-3

Gallacher, Daniel, C. and Achana, Felix A. (2018) Assessing the health economic agreement of different data sources. The Stata Journal, 18 (1). pp. 223-233.

Yang, Jian, Samsel, Paulina A., Narov, Kalin, Jones, Ashley, Gallacher, Daniel C., Gallacher, John, Sampson, Julian R. and Shen, Ming Hong (2017) Combination of everolimus with sorafenib for solid renal tumors in Tsc2+/− Mmce Is superior to everolimus alone. Neoplasia, 19 (2). pp. 112-120. doi:10.1016/j.neo.2016.12.008